Canada markets closed

Rapid Dose Therapeutics Corp. (DOSE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2550+0.0050 (+2.00%)
At close: 10:38AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 26.76M
Enterprise Value 29.35M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)25.33
Price/Book (mrq)26.24
Enterprise Value/Revenue 28.08
Enterprise Value/EBITDA -12.57

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3183.33%
S&P500 52-Week Change 322.36%
52 Week High 30.2750
52 Week Low 30.0900
50-Day Moving Average 30.1850
200-Day Moving Average 30.1546

Share Statistics

Avg Vol (3 month) 335.94k
Avg Vol (10 day) 349.67k
Shares Outstanding 5104.95M
Implied Shares Outstanding 6104.95M
Float 894.58M
% Held by Insiders 19.88%
% Held by Institutions 10.00%
Shares Short (Mar 15, 2024) 41.19k
Short Ratio (Mar 15, 2024) 40.48
Short % of Float (Mar 15, 2024) 4N/A
Short % of Shares Outstanding (Mar 15, 2024) 40.02%
Shares Short (prior month Feb 15, 2024) 42.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Feb 16, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Feb 28, 2023
Most Recent Quarter (mrq)Nov 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-375.72%

Management Effectiveness

Return on Assets (ttm)-80.78%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.05M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-23.50%
Gross Profit (ttm)N/A
EBITDA -2.62M
Net Income Avi to Common (ttm)-3.56M
Diluted EPS (ttm)-0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)166.18k
Total Cash Per Share (mrq)0
Total Debt (mrq)3.02M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.13
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-1.09M
Levered Free Cash Flow (ttm)86.13k